Vytrus Biotech S.A. (VYT) — Cash Flow Quality Index
Vytrus Biotech S.A. (VYT) has a Cash Flow Quality Index of 0.50x as of December 2022. Operating cash flow of €225.55K is below net income of €452.79K, suggesting accrual-heavy earnings not yet converted to cash. Also explore Vytrus Biotech S.A. assets under control for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Vytrus Biotech S.A. Cash Flow Quality Index (2020–2025)
Historical Cash Flow Quality Index for Vytrus Biotech S.A. across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Vytrus Biotech S.A. to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Vytrus Biotech S.A. (2020–2025)
Year-by-year earnings quality comparison for Vytrus Biotech S.A.. For live market cap and the full company financial profile, see Vytrus Biotech S.A. (VYT) market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.35x | €3.90 Million | €2.90 Million | ▼ -25.4% |
| 2024 | 1.81x | €1.84 Million | €1.02 Million | ▲ +8.8% |
| 2023 | 1.66x | €904.39K | €544.94K | ▲ +233.2% |
| 2022 | 0.50x | €225.55K | €452.79K | ▼ -65.6% |
| 2021 | 1.45x | €447.92K | €309.17K | ▲ +200.2% |
| 2020 | -1.45x | €-132.47K | €91.60K | — |